<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-antioxidants-09-01191">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Couillard</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Mauriege</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Imbeault</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Prudâ€™homme</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Nadeau</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Tremblay</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Bouchard</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Despres</surname>
    <given-names>J.P.</given-names>
   </name>
  </person-group>
  <article-title>Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia</article-title>
  <source>Int. J. Obes. Relat. Metab. Disord.</source>
  <year>2000</year>
  <volume>24</volume>
  <fpage>782</fpage>
  <lpage>788</lpage>
  <pub-id pub-id-type="doi">10.1038/sj.ijo.0801227</pub-id>
  <pub-id pub-id-type="pmid">10878687</pub-id>
 </element-citation>
</ref>
